Партнеры и ссылки
Информационные партнеры:
Полезные ссылки:
https://thyronet.rusmedserv.com/
Список литературы:
- Бровкина А. Ф. Эндокринная офтальмопатия. — М.: Гэотар-Медиа, 2004. – 176 с.
- Дедов И. И., Мельниченко Г. А., Фадеев В. В. Эндокринология. – М.: Гэотар-Медиа, 2007. – 109 с.
- Дедов И. И., Мельниченко Г. А., Фадеев В. В. Эндокринология. – М.: Литтерра, 2015. – 412 с.
- Фадеев В.В. То, что вы хотели бы знать о болезни Грейвса – диффузном токсическом зобе. 100 вопросов и ответов – М.: МАИ, 2010.- 62 с.
- Фадеев В.В. То, что вы хотели бы знать о гипотиреозе – недостатке гормонов щитовидной железы – М., 2011.- 25 с.
- Bahn RS. Burch HB, Cooper DS et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 2011; 21: P. 593-646.
- Bartalena L., Baldeschi L., Dickinson A., Eckstein A., Kendall-Taylor P., Marcocci C., et al. Consensus Statement of the European Group on Graves’ Orbitopathy (EUGOGO) on Management of Graves’ Orbitopathy // Thyroid. – 2008. – Vol. 18. – № 3. – P. 333-346.
- Bartalena L., Krassas G.E., at al. Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves’ orbitopathy // J. Clin. Endocrinol. Metab. – 2012. – Vol. 97. – № 12. – P. 4454-4463
- Bartalena L., Marcocci C., Tanda M. L., et al. Cigarette smoking and treatment outcomes in Graves’ ophthalmopathy // Ann. Intern. Med. – 1998. – № 129. – P. 632-635.
- Bartalena L., Pinchera A., Marcocci C. Management of Graves’ ophthalmopathy: reality and perspectives // Endocrine Reviews. – 2000. – Vol. 21. – P. 168-199.
- Bartalena L. The dilemma of how to manage Graves’ hyperthyroidism in patients with asso-ciated orbitopathy. J Clin Endocrinol Metab 2011; 96: 592-599.
- Bartalena L, Tanda ML. Clinical Practice. Graves’ ophthalmopathy. N Engl J Med 2009; 360: 994-1001.
- Eckstein A., Esser J., Mann K., Schott M. Clinical value of TSH receptor antibodies measurement in patients with Graves’ orbitopathy // Pediatr. Endocrinol. Rev. – 2010. – Vol. 7. – № 2. – P. 198-203.
- Krassas G., Wiersinga W. Thyroid Eye Disease: Current Concepts and the EUGOGO Perspective // Thyroid International. – 2005. – № 4. – P. 3-18.
- Marcocci C., Kahaly G., et al Selenium and the Course of Mild Graves’ Orbitopathy // N. Engl. J. Med. – 2011. – Vol. 364. – P. 1920-1931. 16. Mourits M. P., Prummel M. F., Wiersinga W. M., Koornneef L. Clinical activity score as a guide in the management of patients with Graves’ ophthalmopathy // Clin. Endocrinol. – 1997. – Vol. 47. – P.9-14.
- Tanda ML, Lai A, Bartalena L. Relation between Graves’ orbitopathy and radioiodine ther-apy for hyperthyroidism: facts and unsolved questions. Clin Endocrinol (Oxf) 2008; 69: 845-847.
- Wiersinga W. M., Kahaly G. J. Graves’ orbitopathy: a multidisciplinary approach. – B.: Karger, 2007. – 260 p.
- Wiersinga W. M., Kahaly G. J. Graves’ orbitopathy: a multidisciplinary approach. – Questions and Answers. 2nd, revised edition. – B.: Karger, 2010. – 286 p. 20. Zang S., Ponto K. A., Kahaly G. J. Intravenous glucocorticoids for Graves’ orbitopathy: efficacy and morbidity // J. Clin. Endocrinol. Metab. – 2011. – Vol. 96. – № 2. – P. 320-332.